1.0Reproductive Health Access Projecthttps://www.reproductiveaccess.orgReproductive Health Access Projecthttps://www.reproductiveaccess.org/author/reproductive-health-access-project/#MifeNow: Expanding access to medication abortion and early pregnancy loss care - Reproductive Health Access Projectrich600338<blockquote class="wp-embedded-content" data-secret="iJVIfZKw34"><a href="https://www.reproductiveaccess.org/2020/04/mifenow-expanding-access-to-medication-abortion-and-early-pregnancy-loss-care/">#MifeNow: Expanding access to medication abortion and early pregnancy loss care</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://www.reproductiveaccess.org/2020/04/mifenow-expanding-access-to-medication-abortion-and-early-pregnancy-loss-care/embed/#?secret=iJVIfZKw34" width="600" height="338" title="“#MifeNow: Expanding access to medication abortion and early pregnancy loss care” — Reproductive Health Access Project" data-secret="iJVIfZKw34" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript">
/* <![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
/* ]]> */
</script>
https://www.reproductiveaccess.org/wp-content/uploads/2020/04/Miscarriage3-600x600-1.png600600Mifepristone with misoprostol is the safest, most effective way to manage abortion and early pregnancy loss (EPL) with medications. However, regulations on mifepristone make it difficult for primary care clinicians to provide this basic, evidence-based care. Currently, the US Food and Drug Administration regulates mifepristone under a Risk Evaluation and Mitigation Strategy (REMS), which means…